Switch to:
More From Other Websites
Novogen (NVGN) Conducts Scientific Review of R&D Program Aug 31 2015
Novogen Announces The Outcome Of A Comprehensive Science Review Aug 30 2015
Newly Appointed Acting CEO Outlines Immediate Plans for Novogen Jul 29 2015
Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the Board Jul 21 2015
Anisina Receives Orphan Drug Designation from FDA for Neuroblastoma Jul 16 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK